Efficacy and Safety of Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Cell Therapy, and Pembrolizumab in Patients with Immune Checkpoint Inhibitor-Naive Unresectable or Metastatic Melanoma: Updated Results from IOV-COM-202 Cohort 1A.
JOURNAL OF CLINICAL ONCOLOGY（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined